Shares of Talon Therapeutics Inc. (OTC: TLON), a biopharmaceutical company engaged in the development and commercialization of new and differentiated cancer therapies, are climbing in trading today.
At last check, TLON shares were trading 8.57% higher at $1.52 on above average volume of 697,271. The stock touched a new 52-week high of $1.55 in trading today.
According to a filing made by Talon Therapeutics last week, the company’s Board of Directors approved an amendment to the 2006 Employee Stock Purchase Plan increasing the number of shares of TLON common stock available for purchase by 400,000. Under the original plan, the company had reserved 187,000 shares of TLON common stock.
TLON also said in the filing that it has moved its corporate offices to 400 Oyster Point Boulevard, Suite 200, South San Francisco, California.
Recent Comments